Please Note this agenda page is still under development, and will continue to be updated.

Tuesday, May 5 – Patient Advocates

8:30–9:30 am
Location: White Flint Foyer
Registration/Continental Breakfast
9:00-10:30 am
Location: White Flint Amphitheater
10:30am - 10:45am
Location: White Flint Foyer
BREAK
12:30 PM - 1:30 PM
Lunch - Location: Salons G and H
1:30-3:30 pm
Location: White Flint Amphitheater
Q&A with OCE and International Regulators

Panelists:

  • Marc Theoret, MD
  • Paul Kluetz, MD
  • Jan Brun, MSc, PhD (Health Canada, Int’l Regulator)
  • Corneel Coens, MSc

Tuesday, May 5 – Scholars

12:00 PM – 5:30 PM
Location: Salon F
Lunch 12:30 PM – 1:30 PM
with patient advocates
Location: Salon F
Core Curriculum
Faculty:
  • Clinical
    • Nicholas Richardson, MD
    • Mirat Shah, MD
  • Non-clinical
    • Claire Myers, PhD
    • Alyssa Galaro, PhD
  • Clinical Pharmacology
    • Olarewanju Okusanya, PharmD, CP
  • Statistics
    • Jonathon Vallejo, PhD
    • Somak Chatterjee, PhD

Wednesday, May 6

8:30–9:30 am
Location: Foyer D-H/ Foyer-D
Registration/Continental Breakfast
9:30-10:00 am
Location: Salons E-H
Welcome Remarks and Project 2025
10:00-12:00 pm
Location: Salons E-H
Plenary Session 1 - Global Drug Development
12:00-1:00 pm
Salon D
NETWORKING LUNCH
1:00-2:30 pm
IN-DEPTH DISCUSSION GROUP I
(Learners attend one from this list)
1:00-2:30 pm
1. AAADV 2020 Supportive and Palliative Care Discussion Session
(Patient Advocates)
Panelists:
1:00-2:30 pm
4. Sexual and Gender Minority in Oncology (Patient Advocates)
Panelists:
1:00-2:30 pm
5. Placeholder for hot topics and late/breaking sessions (optional)
2:30–3:00 pm
Location: Foyer D - H
Break
3:00–5:00 pm
Location: Salons E – H
Anatomy of a Drug Approval (Choose 1 to attend)
  1. zanubrutinib (Brukinsa, for mantle cell lymphoma)
  2. erdafitinib (Balversa, for FGFR-mutated urothelial cancer)
  3. pexidartinib (Turalio, for tenosynovial giant cell tumor)
  4. pembrolizumab+lenvatinib (Keytruda+Lenvima, for endometrial cancer)
5:00–7:00 pm
Location: Veranda outside; bad weather Salons E-H Foyer inside
Welcome Network Reception

Thursday, May 7th

8:30–9:30 am
Location: Salon D
Continental Breakfast

Informal Breakfast Discussion Groups for New Learners and Patient Advocates

9:30-10:30 am
Location: Salons E-H
Introduction of Keynote Speaker
Keynote Address
Plenary Session 2 - Using Artificial Intelligence and Machine Learning to Inform Oncology Patient Care
Note: Audience Polling Session
Panelists:
12:30-1:30 pm
Location: Salon D
NETWORKING LUNCH
1:30-3:00 pm
IN-DEPTH DISCUSSION GROUP II
(Learners attend one from this list)
1:30-3:00 pm
1. Learning from other diseases: HIV and Oncology (Patient Advocates)
Panelists:
1:30-3:00 pm
2. Biosimilars (International regulators)
Panelists:
1:30-3:00 pm
4. Immune-Related Adverse Events: Learning from Our Mistakes and Doing Better for Our Patients
(Patient Advocates)
Panelists:
1:30-3:00 pm
5. Placeholder for Hot Topics and Late/Breaking Sessions
Location: Brookside A&B
3:00–3:30 pm
Location: Salon D - H Foyer
Break
3:30–5:30 pm
Location: Salons E-H
Anatomy of a Drug Approval
(Choose 1 to attend)
  • zanubrutinib (Brukinsa, for mantle cell lymphoma)
  • erdafitinib (Balversa, for FGFR-mutated urothelial cancer)
  • pexidartinib (Turalio, for tenosynovial giant cell tumor)
  • pembrolizumab+lenvatinib (Keytruda+Lenvima, for endometrial cancer)
5:30–6:30 pm
Location: Veranda outside; bad weather Salons E-H Foyer inside
Network Reception

Friday, May 8th

8:30–9:30 am
Location: Salon D
Informal Breakfast Discussion Groups for New Learners and Patient Advocates Continental Breakfast
9:30-11:00 am
IN-DEPTH DISCUSSION GROUP III (Learners attend one from this list)
9:30-11:00 am
1. Immune-Related Adverse Events: Learning from Our Mistakes and Doing Better for Our Patients
(Patient Advocates)
Panelists:
9:30-11:00 am
2. Pediatric Drug Development and FDARA
Location: Salon G
Panelists:
  • Danielle Leach, MPA (Patient Advocate)
  • Vivek Subbiah, MD
  • Eric Ng, MD
  • Victor Santana, MD
9:30-11:00 am
3. Biosimilars (International regulators)
Panelists:
  • Stacey Ricci, MEng, ScD
  • Mark Fleury, PhD
  • Christine Simmon, JD
  • Donald Harvey, PharmD
  • Bradley Scott, PhD (Health Canada, Int’l Regulator)
  • Christine Hodgdon (Patient Advocate)
9:30-11:00 am
11:00am
Location: Salon D
AAADV Workshop Adjourn
BOX LUNCHES (TO GO)
12:00pm
Location: White Flint Amphitheater
Satellite Session

Topic: The Assessment of Value in Cancer Care

0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *